MRI detects myocardial iron in the human heart

Iron‐induced cardiac dysfunction is a leading cause of death in transfusion‐dependent anemia. MRI relaxation rates R2(1/T2) and R  2* (1/T  2* ) accurately predict liver iron concentration, but their ability to predict cardiac iron has been challenged by some investigators. Studies in animal models support similar R2 and R  2* behavior with heart and liver iron, but human studies are lacking. To determine the relationship between MRI relaxivities and cardiac iron, regional variations in R2 and R  2* were compared with iron distribution in one freshly deceased, unfixed, iron‐loaded heart. R2 and R  2* were proportionally related to regional iron concentrations and highly concordant with one another within the interventricular septum. A comparison of postmortem and in vitro measurements supports the notion that cardiac R  2* should be assessed in the septum rather than the whole heart. These data, along with measurements from controls, provide bounds on MRI‐iron calibration curves in human heart and further support the clinical use of cardiac MRI in iron‐overload syndromes. Magn Reson Med, 2006. © 2006 Wiley‐Liss, Inc.

[1]  B. Gersh,et al.  Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. , 1987, Journal of the American College of Cardiology.

[2]  D. Pennell,et al.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia , 2002, The Lancet.

[3]  W. Roberts,et al.  Iron in the heart. Etiology and clinical significance. , 1971, The American journal of medicine.

[4]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[5]  T. S. St. Pierre,et al.  Proton transverse relaxation rate (R2) images of iron‐loaded liver tissuepping local tissue iron concentrations with MRI , 2003 .

[6]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[7]  R. Engelhardt,et al.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility , 2003, The Lancet.

[8]  Marvin D Nelson,et al.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. , 2004, Blood.

[9]  A. Piga,et al.  SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR , 1989, The Lancet.

[10]  Huaqing Zhao,et al.  1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. , 2005, Radiology.

[11]  T. S. St. Pierre,et al.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.

[12]  A. Myking,et al.  Multi-element analysis of trace element levels in human autopsy tissues by using inductively coupled atomic emission spectrometry technique (ICP-AES). , 2002, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[13]  J. H. MacMillan,et al.  Survival in medically treated patients with homozygous beta-thalassemia. , 1994, The New England journal of medicine.

[14]  D. Fitchett,et al.  Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. , 1980, Cardiovascular research.

[15]  T. Coates,et al.  Improved R2* measurements in myocardial iron overload , 2006, Journal of magnetic resonance imaging : JMRI.

[16]  C Henssge,et al.  Death time estimation in case work. I. The rectal temperature time of death nomogram. , 1988, Forensic science international.

[17]  D. Pennell,et al.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility , 2003, The Lancet.

[18]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[19]  T. S. St. Pierre.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. , 2003, Lancet.